
Breastfeeding while mother or baby is sick provides benefits to both
November 21, 2019
Slight decrease in new HIV cases except in foreign men
November 29, 2019The objective is to directly support researchers and research groups
The Aragón Health Research Institute (IIS Aragón) has delivered the aid corresponding to the fifth edition of the Intramural Call for the Promotion of Research IIS Aragón 2019, which aims to support researchers and research groups from this institute that stand out for their scientific or innovative production. Endowed with a total of 220.000 euros, it includes several categories, whose aid will be allocated to resident researchers, best research groups, innovation projects and the hiring of faculty personnel to promote their research activity.
The aid has been delivered at the Research and Innovation Conference, which has been inaugurated by the Minister of Health of the Government of Aragon, Pilar Ventura, who has reviewed the "new challenges" that health research faces, as well as the rector of the University of Zaragoza, José Antonio Mayoral, and by the scientific director of the IIS Aragón, Ángel Lanas, who has highlighted the work of the Institute indicating that “the IIS Aragón maintains its commitment to supporting health research in Aragon and empowering young health professionals who want to guide his career to research.”
Josep Piqué Badía, member of the External Scientific Committee of the IIS Aragón, gave the presentation 'The future in our hands', and Jesús Santamaría Ramiro, vice-director of the Nanoscience Institute of Aragón and researcher at the IIS Aragón, spoke with the conference 'Changing the paradigm in chemotherapy: generating toxic molecules within the tumor'.
Subsequently, aid has been delivered in the different categories:
Resident Researcher Category
This award supports residents integrated into the IIS Aragón groups with funding for a stay in a center of international prestige, facilitating their research work. In total, six grants have been granted. Of them, two have been for researchers from the 'Digestive Pathology' groups, another two have been awarded to the 'Vision, Image and Neurodevelopment' group and two have also gone to the 'Medical Oncology' group.
“Rector Manuel Pérez” Category for Best Research Group
This aid recognizes the research work of the IIS Aragón Groups and has three categories: Associated Group, Emerging Group and Consolidated Group.
The Consolidated Group award went to 'Primary Dyslipidemias', whose main researcher is Fernando Civeira Murillo. His line of research focuses on inflammatory markers and arteriosclerosis in autosomal dominant hypercholesterolemias (ADH).
The award in the Emerging category has gone to the group 'Vision, Image and Neurodevelopment', whose main researcher is Victoria Pueyo Royo, who focuses on researching new tests to explore vision and the study of neurodevelopment and vision in childhood early.
In the Associate category, the 'Surgical Pathology of the Thorax' group has been distinguished, whose principal investigator is Raúl Embún Flor, who investigates predictive models of postoperative morbidity and mortality in major lung resection.
Best Innovation Project Category
In this call, two initiatives have been selected that will make it possible to achieve important advances in the control of hemorrhage and in the detection and treatment of glioblastoma (a type of brain tumor). The project 'Development of instruction and training simulator for hemorrhage control (compressible, non-compressible and junctional)' aims to build a simulation system, which is anatomically similar to that of a patient, to train healthcare personnel in these three types of hemorrhages. This simulator has been presented by the 'Clinical and Experimental Surgical' research group, whose main researcher is Antonio Güemes Sánchez.
The other project, 'Detection in glioblastomas of new biomarkers of progression of resistance to chemotherapy in in vitro biometric models', aims to detect the markers of evolution of the resistance of the cells of these brain tumors to define better and more personalized treatment schemes. . The project is from the Bio MicroEnvironmmet Lab (BME Lab) research group and Ignacio Ochoa Garrido is its principal investigator.
Both projects stand out for the collaboration between researchers belonging to research groups of the Technologies and Innovation Program applied to Health, and clinical researchers belonging to other research programs of the IIS Aragón.
Intramural-PostFSE Category
This aid promotes the incorporation of physicians who have recently completed their specialized training in hospital or primary care centers, having to allocate at least 50% of their working day to training in research.
Within the Post-FSE I Support Action, the aid has gone to María Pilar Navarro Pérez, who will join the Monographic Headache Consultation at the Lozano Blesa Clinical Hospital and whose research will focus on the study of alterations in the secretion pattern of melatonin by determining the “dim light melatonin onset” (DLMO) in patients with episodic migraine.
For its part, the Post-ESF Support Action II, which is co-financed by ASPANOA with 30.000 euros in two annual payments, has gone to Yurena Aguilar de la Red, who will join the Pediatric Oncotherapy Unit of the Miguel Servet University Hospital to implement transversal lines of research related to the development of nanotechnology tools focused on therapy and diagnosis in childhood cancer.
Aragon Health Research Institute
The IIS Aragón is the Health Research Institute of the Hospital Complex formed by the Lozano Blesa University Clinical Hospital, the Miguel Servet University Hospital and Primary Care of the Aragonese Health Service together with the University of Zaragoza and the Aragonese Institute of Health Sciences. With more than 90 research groups structured into 6 programs, the IIS Aragón integrates health professionals, researchers and teachers, bringing together basic and applied, clinical and health services research, to create a quality scientific, healthcare and training environment.